Novo Nordisk Targets Smart Insulin, Stem Cell-Therapies

Its CEO Sees Glucose-Responsive Insulin Trials ‘Within Two Years’

 
• By Sten Stovall
  
Novo_Nordisk
Novo Nordisk Is Denmark-based • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip